Acrux Signs 10-Year Licensing Deal For Dapsone Gel in Saudi Arabia

MT Newswires Live

2025/07/31

Acrux (ASX:ACR) has signed a 10-year agreement with Servacure Trading to market and distribute its food and drug administration-approved Dapsone 5% Gel in Saudi Arabia, according to a Thursday filing with the Australian bourse.

The product, launched in the US in April 2024 for treating acne vulgaris and available in 60g and 90g packs, will have its regulatory approval and manufacturing managed by Servacure under the agreement, the filing said.

The company will earn a fixed fee per unit shipped monthly, with options to renew the contract after the initial term, the filing added.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2555052990"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2555052990\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2555052990?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-07-31 14:16","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2555052990","market":"sg","top_or_hot":-1,"title":"Acrux Signs 10-Year Licensing Deal For Dapsone Gel in Saudi Arabia","media":"MT Newswires Live","content":"<html><body><p> Acrux (ASX:ACR) has signed a 10-year agreement with Servacure Trading to market and distribute its food and drug administration-approved Dapsone 5% Gel in Saudi Arabia, according to a Thursday filing with the Australian bourse.</p><p>The product, launched in the US in April 2024 for treating acne vulgaris and available in 60g and 90g packs, will have its regulatory approval and manufacturing managed by Servacure under the agreement, the filing said.</p><p>The company will earn a fixed fee per unit shipped monthly, with options to renew the contract after the initial term, the filing added.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Acrux Signs 10-Year Licensing Deal For Dapsone Gel in Saudi Arabia</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAcrux Signs 10-Year Licensing Deal For Dapsone Gel in Saudi Arabia\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2025-07-31 14:16</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> Acrux (ASX:ACR) has signed a 10-year agreement with Servacure Trading to market and distribute its food and drug administration-approved Dapsone 5% Gel in Saudi Arabia, according to a Thursday filing with the Australian bourse.</p><p>The product, launched in the US in April 2024 for treating acne vulgaris and available in 60g and 90g packs, will have its regulatory approval and manufacturing managed by Servacure under the agreement, the filing said.</p><p>The company will earn a fixed fee per unit shipped monthly, with options to renew the contract after the initial term, the filing added.</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ACR.AU","symbol_name":"ACRUX LTD","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2555052990","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2555052990","pubTimestamp":1753942573,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Acrux  has signed a 10-year agreement with Servacure Trading to market and distribute its food and drug administration-approved Dapsone 5% Gel in Saudi Arabia, according to a Thursday filing with the Australian bourse.The product, launched in the US in April 2024 for treating acne vulgaris and available in 60g and 90g packs, will have its regulatory approval and manufacturing managed by Servacure under the agreement, the filing said.The company will earn a fixed fee per unit shipped monthly, with options to renew the contract after the initial term, the filing added.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ACR.AU":"ACRUX LTD","BK7096":"制药","BK7508":"医药生物股"},"translate_title":"Acrux在沙特阿拉伯签署为期10年的氨苯砜凝胶许可协议","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ACR.AU":0.9},"content_text":"Acrux (ASX:ACR) has signed a 10-year agreement with Servacure Trading to market and distribute its food and drug administration-approved Dapsone 5% Gel in Saudi Arabia, according to a Thursday filing with the Australian bourse.The product, launched in the US in April 2024 for treating acne vulgaris and available in 60g and 90g packs, will have its regulatory approval and manufacturing managed by Servacure under the agreement, the filing said.The company will earn a fixed fee per unit shipped monthly, with options to renew the contract after the initial term, the filing added.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}